Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinopharm Group Dezhong (Foshan) Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, manufacturing, and marketing of Traditional Chinese Medicine (TCM) and over-the-counter (OTC) drugs. Originally founded in 1971 as the state-owned Foshan No. 2 Pharmaceutical Factory, the company was restructured in 1998 and later acquired by China Traditional Chinese Medicine Holdings (China TCM), a subsidiary of Sinopharm. Dezhong is recognized as a 'Chinese Time-Honored Brand' (Zhonghua Laozihao) and holds numerous national drug approvals and patents. Its flagship products include BiYanKang Tablets (for rhinitis), Yangxue Shengfa Capsules (for hair loss), and Yuan Jilin Sweet and Herbal Tea. The company operates advanced manufacturing facilities in Foshan, Guangdong, utilizing modern pharmaceutical technologies such as continuous extraction and spray drying to produce high-quality TCM products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dezhong National Medicine Group.